Surgical correction of initial CHP is successful

Article

Compensatory head posture is reversed after Anderson-Kestenbaum surgery.

Compensatory head posture is reversed after Anderson-Kestenbaum surgery, according to a paper in the European Journal of Ophthalmology.

Dr Silay Canturk Ugurbas et al., Department of Ophthalmology, Zonguldak Karaelmas, University Faculty of Medicine, Turkey, conducted a retrospective chart review on four patients with cogenital nystagmus. The participants presented with a new version of their original horizontal compensatory head posture (CHP) or a reversal of CHP after Anderson-Kestenbaum surgery.

At the time of initial surgery, all patients had a 40–45° horizontal face turn and to correct the CHP three patients underwent 20% and one experienced 30% augmented A-K surgery. Reversal of the original CHP was recorded for an average of four years postoperatively.

The results showed that the reversed CHPs measured 20°, 40°, 20° and 20°, respectively. In all patients an acceptable head position was achieved and in three patients.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.